Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Prioritizing goals helps you tackle the most impactful tasks first, improving momentum and overall financial health.
19,975 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Jaguar (JAGX) 2025 earnings show a company shifting from product-driven revenue to licensing cash. This piece breaks ...
A high-earning worker with a $2.2 million 401(K) balance faces a five-year choice on Roth conversion. Experts say tim...
A rare ‘super’ niño looking could intensify weather extremes this year, impacting crops, energy costs, and budgets. H...
Berkshire Hathaway unveils a major acquisition for $8.5 billion, signaling Greg Abel’s first big, contrarian bet as t...
A 65-year-old widow faces a pivotal decision: switch to her own Social Security benefit now or wait, risking a smalle...
Markets brace for Kevin Warsh’s first policy meeting as chair, with expectations for a steady rate path and close att...
Austin reels after the death of Joshua Baer, the founder who helped mold the city’s tech economy. The loss raises que...
Temasek unveils a sweeping leadership overhaul, elevating its CFO into a central strategic role as the group reorgani...
SoFi stock is showing signs of a renewed uptrend as growth catalysts and insider activity bolster a case for double-d...
When a company’s chairman unloads a sizable stake, investors naturally want to know why. This article breaks down a r...
The Ebola outbreak in the Democratic Republic of Congo has intensified as aid budgets shrink. Experts warn that the r...